Vanguard Global Advisers »

Fibrobiologics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Fibrobiologics shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $708 536 1.32

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Fibrobiologics

Vanguard Capital Management
Fund Evaluation Group
Geode Capital Management
BlackRock
Cascade Financial Partners
Vanguard Fiduciary Trust
UBS Group
Goss Wealth Management
Vanguard Global Advisers
Royal Bank of Canada
Islay Capital Management
Bnp Paribas Arbitrage, Snc
Wells Fargo & Company

View all funds holding Fibrobiologics